Delivery Order SPE2DB20D2104-SPE2DB25FMLXG
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has an ultimate completion date of May 28, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a $1,088.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The delivery order has an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,499.81 contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a performance period ending on May 6, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,984.38 contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication. The award has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,088.36, is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,878.34, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,909.55 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a $2,504.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes treatment medication, with a performance period ending on June 16, 2025. This award is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
This is a $2,667.23 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication. The order has an ultimate completion date of June 24, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,265.08 contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication. The award has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...